| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Julia Letlow LA05 | 1 | +$8.0K | Bought Oct 22, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Oct 22, 25 | Julia Letlow LA05 | Self | Buy | $1,001 - $15,000 | Jan 13, 26 (83d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 17, 2025 | Engstrom (E N Nils) | Sold at price 50.91 per share. | 20.3K | $1.03M |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -11.4 | -2.8 | -4.7 | 10.4 | -10.4 | -3.4 | 11.8 | 2.9 | -8.9 | 10.1 | −9.6% | ||
| 2025 | 9.8 | -3.0 | 4.2 | 8.4 | -1.3 | 0.8 | -4.5 | -10.1 | 2.3 | -7.4 | -9.1 | 0.5 | −11.0% |
| 2024 | 4.3 | 6.2 | -1.4 | -4.9 | 6.7 | 4.4 | 2.9 | -1.2 | 1.7 | -2.6 | 1.9 | -3.5 | +14.5% |
| 2023 | 7.2 | 2.0 | 7.1 | 2.1 | -5.5 | 6.8 | 0.7 | -3.4 | 3.6 | 3.4 | 10.7 | 2.8 | +43.1% |
| 2022 | -6.1 | -0.3 | 1.9 | -5.3 | -2.8 | -5.9 | 9.6 | -11.3 | -7.1 | 10.9 | 4.5 | -1.6 | −15.0% |
| 2021 | 0.6 | -5.4 | 7.1 | 3.7 | 0.2 | 2.1 | 11.1 | 1.8 | -4.3 | 8.1 | -0.6 | 5.2 | +32.2% |
| 2020 | 5.0 | -9.0 | -11.4 | 5.9 | 2.8 | 1.2 | -10.1 | 7.0 | -1.3 | -11.8 | 18.5 | 5.5 | −2.4% |
| 2019 | 8.1 | 3.9 | -6.9 | 6.9 | 1.9 | 4.5 | -2.8 | 1.3 | -1.4 | 2.0 | 0.8 | 3.7 | +23.1% |
| 2018 | -7.6 | -5.7 | 1.1 | 3.5 | 3.2 | -2.6 | 1.0 | 1.6 | -6.1 | -6.1 | 6.7 | -2.2 | −13.4% |
| 2017 | 1.3 | 4.4 | 4.2 | 3.5 | 5.8 | 1.0 | 1.0 | 0.3 | 0.8 | 4.7 | 1.6 | -0.3 | +31.9% |
| 2016 | -0.1 | -2.2 | 7.9 | -4.3 | 2.6 | 1.4 | 3.1 | -0.4 | -0.3 | -5.3 | -4.4 | 3.6 | +0.8% |
| 2015 | 2.1 | -0.7 | -0.2 | -4.0 | 0.4 | -2.1 | 7.6 | -7.9 | 8.0 | 3.6 | 0.6 | -1.6 | +4.8% |
| 2014 | -2.6 | 5.1 | -0.1 | -3.7 | 8.1 | 1.2 | -0.4 | 2.0 | -2.0 | 2.0 | 5.4 | -1.8 | +13.3% |
| 2013 | 3.5 | -1.1 | 10.4 | -1.9 | -3.4 | 1.3 | 13.6 | -5.4 | 10.0 | 4.2 | 3.1 | 3.7 | +42.8% |
| 2012 | 2.7 | 5.5 | 1.2 | -6.6 | -10.5 | 8.3 | 5.2 | 11.0 | 2.1 | 2.3 | 5.7 | 1.8 | +30.3% |
| 2011 | 6.2 | 0.3 | -3.1 | 2.7 | 2.3 | 0.3 | -0.2 | -9.6 | -7.5 | 12.4 | -2.6 | -3.1 | −3.9% |
| 2010 | -2.9 | -5.4 | 6.5 | -1.5 | -11.4 | 4.7 | 18.5 | -7.7 | 5.4 | 1.7 | -7.5 | 5.8 | +2.3% |
| 2009 | 1.0 | -1.1 | -4.4 | 3.9 | 9.8 | -8.3 | -4.9 | 1.9 | 4.2 | 0.3 | 0.1 | 8.6 | +9.9% |
| 2008 | -10.1 | 3.3 | 1.9 | -0.8 | -0.8 | -9.3 | -0.4 | 1.0 | -12.4 | -11.9 | -5.7 | -10.5 | −44.6% |
| 2007 | 4.1 | 1.9 | 2.8 | 5.2 | 6.9 | -4.3 | -4.5 | -2.2 | 4.5 | 4.4 | -4.6 | 7.3 | +22.4% |
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Buy / hold / sell counts